Citigroup Maintains Buy on Biomea Fusion, Raises Price Target to $7

Citigroup analyst Yigal Nochomovitz has maintained a 'Buy' rating on Biomea Fusion (NASDAQ: BMEA) and raised the price target from $6 to $7. This adjustment reflects a positive outlook for the company's performance.